Curing blindness through regenerative cell therapies. We replace what is lost.

StemSight develops off-the-shelf cell therapies to address unmet medical needs in corneal blindness. ​

We are the pioneers of combining iPS-derived cells with functional biomaterials. Our primary goal is to accelerate tissue regeneration, enhance the safety of cell therapies, and simplify cell delivery.

<p><span>The most innovative startup in health and life sciences in Europe at BioFit, 2020</span></p>

The most innovative startup in health and life sciences in Europe at BioFit, 2020

Award winner at TechTour’s flagship event, Europe’s Most Innovative Companies, 2022
Award winner at TechTour’s flagship event, Europe’s Most Innovative Companies, 2022
Finalist at EIT Health Catapult Biotech pitching competition, 2022-2023
Finalist at EIT Health Catapult Biotech pitching competition, 2022-2023

About us

The founding team of StemSight is comprised of top scientists in regenerative medicine and tissue engineering for eye applications. The scientific excellence is complemented by our distinguished board of accomplished industry leaders and advisors with extensive global business acumen.
READ MORE

Latest News

2025-08-15 00:00:00

StemSight featured in Technology Networks

StemSight's CEO Laura Koivusalo interviewed by Blake Forman for  Technology Networks article. The news piece nicely captures StemSight's groundbreaking work in aiming to cure blindness with stem cells.

 

 

2025-06-06 00:00:00

StemSight appoints Maarit Merla to Board of Directors

StemSight welcomes Maarit Merla to StemSight’s Board of Directors!
Maarit is the CEO of the Finnish Drug Discovery Center Ltd. and brings nearly 25 years of leadership experience across biotech, pharma, and medtech. Her track record includes raising €9M in funding, leading strategic partnerships like Forendo Pharma’s collaboration with Novartis, and playing a key role in the company’s acquisition by Organon.

 

2025-06-12 00:00:00

Laura Koivusalo named Research Entrepreneur of the Year

Our CEO Laura has been awarded the title of Research Entrepreneur of the Year by the Finnish Science Foundation for Economics and Technology (KAUTE Foundation). The award is a recognition for Laura's persistent work and bold choices in building StemSight. You can read the full post and Laura's interview on the KAUTE foundation's website. 

 

 

2025-05-23 00:00:00

StemSight recognized as one of the hottest biotechs in Finland

Labiotech.eu has featured StemSight among the top nine biotechnology companies to watch in Finland. We are excited to be highlighted among such great companies!

 
More News

Want to know more?

Interested to join our next investment round? Want to hear about our latest developments? Just thought of someone we absolutely need to meet?

Send us a message!

CONTACT US

Subscribe to our newsletter

Subscribe now

Supported by:

Co-funded by: